SYK Gross Margin Analysis

Gross margin is the percentage of revenue a company keeps after paying the direct costs of producing its medical devices, so a 63.3% gross margin means SYK retains $0.63 of every sales dollar before other expenses.

This level sits well above the sector median of 44.7%, placing SYK in the 77th percentile among its peers, which indicates a high-cost efficiency advantage. However, the trend is not available: both year-over-year and quarter-over-quarter changes are N/A, so there is no evidence of whether this margin is improving or deteriorating. The combination of a high current margin with missing trend data limits both upside confirmation and downside warning, creating an evenly balanced risk profile. This metric supports the overall NEUTRAL verdict because the strong level is counterbalanced by the absence of trend direction, leaving no clear reason to favor or avoid the stock.

Frequently Asked Questions